Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jianfeng Pharmaceutical, a core subsidiary of the Zhejiang Jianfeng Group, is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of finished dosage forms and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio with a strong focus on anti-infectives, cardiovascular treatments, and gastrointestinal medications. Jianfeng operates multiple GMP-certified manufacturing facilities and has established a significant market presence in China through its integrated production and distribution capabilities. In addition to its commercial operations, the company invests in the development of generic drugs and improved formulations to address prevalent health needs in the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jianfeng Zhu.